Ardelyx Inc. buy me8
Start price
30.11.21
/
0%
€0.99
Target price
30.11.22
€1.00
Performance (%)
36.36%
End price
11.12.21
€1.35
Summary
This prediction ended on 11.12.21 with a price of €1.35. The BUY prediction by me8 for Ardelyx Inc. saw massive gains of 36.36%. This prediction was marked as speculative and is excluded from me8's performance statistics.Ardelyx, Inc. is a biopharmaceutical company that focuses on the research, development, and commercialization of innovative medicines aimed at treating kidney and cardiovascular diseases. The company uses a unique approach to drug discovery, developing therapeutics that target ion channels and transporters, which play a critical role in regulating activities in the body. Ardelyx's lead product candidate, tenapanor, is being studied for the treatment of conditions such as hyperphosphatemia in patients with chronic kidney disease, irritable bowel syndrome with constipation, and diverticulosis. The company is listed on the NASDAQ exchange under the ticker symbol ARDX.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ardelyx Inc. | -0.836% | -0.836% | 59.355% |
| iShares Core DAX® | -2.926% | -4.228% | 9.878% |
| iShares Nasdaq 100 | 4.462% | 8.605% | 33.063% |
| iShares Nikkei 225® | 0.306% | 0.284% | 3.871% |
| iShares S&P 500 | 2.488% | 4.773% | 27.189% |
According to me8 what are the pros and cons of Ardelyx Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Good culture
Innovative
Cons
Few uniques
Comments by me8 for this prediction
In the thread Ardelyx Inc. diskutieren
Buy Ardelyx Inc.
Kursziel gesetzt auf 1,0
In the thread Trading Ardelyx Inc.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.